REFERENCES
- Freeman, J. V., Varosy, P., Price, M. J., Slotwiner, D., Kusumoto, F.
M., Rammohan, C and Masoudi, F. A. The NCDR left atrial appendage
occlusion registry. Journal of the American College of Cardiology
2020 75(13), 1503-1518.
- Kar, S., Doshi, S. K., Sadhu, A., Horton, R., Osorio, J., Ellis, C.
and PINNACLE FLX Investigators. Primary Outcome Evaluation of a
Next-Generation Left Atrial Appendage Closure Device: Results From the
PINNACLE FLX Trial. Circulation. 2021 143(18), 1754-1762.
- Schmidt B, Betts TR, Sievert H, et al. Incidence of pericardial
effusion after left atrial appendage closure: the impact of underlying
heart rhythm— data from the EWOLUTION study. J Cardiovasc
Electrophysiol 2018;29:973–8.
- Reddy VY, Gibson DN, Kar S, et al. Post-FDA approval, initial U.S.
clinical experience with Watchman left atrial appendage closure for
stroke prevention in atrial fibrillation. J Am Coll Cardiol
2017;69:253–61.
- Nandkeolyar S, Parwani P, Contractor T. A Case of Delayed Hemorrhagic
Effusive-Constrictive Pericarditis After Left Atrial Appendage
Occlusion Device Placement. JACC: ase Reports. 2019;1(1):27-31.